Posts

Pennington Biomedical’s Dr. Steven Heymsfield and colle...

In the long history of recommendations for nutritional intake, current research ...

Immunotherapy post-surgery improves overall survival fo...

Boston – For the first time in fifty years, results from a phase 3 randomized, p...

Association for Computing Machinery publishes first iss...

ACM, the Association for Computing Machinery, has announced the publication of t...

International group runs simulations capable of describ...

A consortium made up of researchers from more than ten countries, including Braz...

Atom-by-atom: Imaging structural transformations in 2D ...

Silicon-based electronics are approaching their physical limitations and new mat...

Protecting brain cells with cannabinol

LA JOLLA (April 17, 2024)—One in every 10 individuals above the age of 65 develo...

From dreams to reality: unveiling the ideal in situ con...

As the lunar exploration mission evolves from exploration to construction and ut...

Advancing performance assessment of a spectral beam spl...

As the globe grapples with the urgent need to shift from fossil fuels to sustain...

From theory to practice: Study demonstrates high CO2 st...

A new study published in Engineering unveils the remarkable carbon storage poten...

Eco-friendly glue designed by Cal Poly, Geisys Ventures...

Contact: Nick Wilson 805-235-8008; nwilso28@calpoly.edu Credit: NICK WILSON Cont...

Recycling CFRP waste is a challenge, but we’ve found a ...

Carbon fiber reinforced plastics (CFRP) are lighter and stronger than metal and ...

With its squishy synthetic platelets, the startup SelSy...

Platelets are always in low supply with an additional problem with these sticky ...

Risk adjusted net present value: What is the current va...

ABBV-400 is a monoclonal antibody conjugated commercialized by AbbVie, with a le...

Risk adjusted net present value: What is the current va...

Sabestomig is a monoclonal antibody commercialized by AstraZeneca, with a leadin...

Risk adjusted net present value: What is the current va...

AZD-9574 is a small molecule commercialized by AstraZeneca, with a leading Phase...

Risk adjusted net present value: What is the current va...

MK-1084 is a small molecule commercialized by Merck, with a leading Phase I prog...